Introduction
Estrogens play a key role in the gonadal differentiation of birds. During embryogenesis, 17beta-estradiol (E2), the most potent endogenous estrogen, acts as a morphogen for the development of female characteristics [1] . Traditionally, estrogens have been considered to be primarily female hormones. However, estrogens also play an important role in male development [1] . Estrogen secretion in boars can influence the development of the somatic cells within the testis that ultimately contribute to testicular size and sperm production [2] . The estrogen receptors α and β are expressed throughout the male reproductive tract, including in germ cells in a number of species [3] . In Hess et al. [3] , when the estrogen receptor α was knocked out in mice, the males became infertile, primarily because of malfunction of the efferent ductules of the epididymis, with consequent gross disruption of the seminiferous tubules.
Experimental data also suggest that the chicken estrogens could be involved in gonadal development [4] . However, expression of estradiol receptor mRNA was not detected in gonads of either male or female chickens until the seventh day of incubation [5] . In chicken primordial germ cells (PGCs), migration has been reported to originate from the epiblast to reach the hypoblast of the area pellucida after several hours of incubation [5] . What controls the chicken PGC migration in . 244 .
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http://www.asiaandro.com; aja@sibs.ac.cn vivo is still poorly understood. The present study investigated the effects of E2, given at different stages of development, on the migration of chicken PGCs in gonads of male and female embryos from the initial stage until completion of their settlement in the gonadal primordium.
Materials and methods

Chicken eggs and preparation of 17beta-estradiolsolution
Fertilized White Leghorn (Gallus domesticus) eggs weighing 63.0 g ± 2.0 g (mean ± SD) were obtained from the Experimental Station of China Agricultural University. 17beta-estradiol (E2) (Sigma, St. Louis, MO, USA) was dissolved in a peanut oil/lecithin mixture (9:1, wt/wt) and then the oil/lecithin mixture was emulsified in water (1: 1.5, vol/vol) at a final concentration of 80 µg/0.l mL [6] . The standard injection volume chosen were 100 µL/egg or embryo and a control 100 µL of the vehicle (emulsion) were similarly injected.
The dose of E2 was similar to the dose used previously in White Leghorn eggs [7] , to ensure that significant effects could be demonstrated with E2 treatment.
Experimental design
Developmental stages of chicken embryos were expressed according to the normal tables of Eyal-Giladi and Kochav (before incubation in Roman numerals), or Hamburger and Hamilton (after incubation in Arabic numerals). All embryos were sexed by polymerase chain reaction (PCR) amplification of a W-specific XhoI repeat from a genomic DNA template. The group size treated with E2 or vehicle must be sufficient for assessment of PGCs at different stages. The embryo number of random investigation for every result (Tables 1 and 2 ) is 10.
Estradiol treatments and incubation
At stage X, shell windowing was as descried by Speksnijder and Ivarie [8] . The eggs were swabbed with 70% ethanol and placed horizontally with respect to their long axis for approximately 2 h. Using a dental drill, a window of approximately 5 mm in diameter was ground through the shell near the top of the air cell of the still horizontally placed egg. Thereafter, the newly ground hole was swabbed with 70% ethanol and the shell membrane was cut cleanly around the window. The underlying blastoderm was located by turning the egg under illumination using a fiber optic light source (Nikon SMZ-10, Tokyo, Japan). Injection was into the yolk at the vicinity of the blastoderm with a 27-gauge syringe; the windows were then sealed with a coverslip and paraffin wax, and the sealed eggs were further incubated at 38ºC and 70% relative humidity until the end of stages 8-10, or 13-15 or 28-30, at which time the embryos were removed and killed.
E2 was similarly injected into the yolk at stages 8-10 and 13-15, as above. However, the embryo becomes distinguishable at these stages, and moves easily in the shell, and not need place horizontally some time for cutting a hole.
Primordial germ cell collection and staining 2.4.1 Primordial germ cell collection from the germinal crescent
At 30 h of incubation (stages 8-10), the germinal crescent PGCs were dissected according to Speksnijder and Ivarie [8] . A filter paper ring was placed around each developing embryo, and the vitelline membrane was cut around the outside of the ring. The ring with the adhering germinal crescent was removed from the yolk and placed ventral side up in sterile phosphate buffered saline (PBS) containing 5.6 mmol/L D-glucose (PBS-G). Yolk was removed from the embryo by microdissection and gentle rinsing with PBS-G, and the separated germinal crescent was dissociated in 0.25% (wt/vol) trypsin solution supplemented with 0.05% (wt/vol) EDTA by gentle pipetting. After the inactivation of trypsin-EDTA with MEM (minimum essential medium) containing 10% fetal bovine serum, the cells were harvested by centrifugation at 300 × g for 5 min at normal temperature.
Primordial germ cell collection from gonad
After 132 h of incubation when the embryos were at stages 28-30, the eggs were removed, rinsed with PBS-G to remove the yolk, and the abdomen of the embryos was carefully dissected under a stereoscope and the gonads were collected with sharp tweezers. Gonadal tissues were dissociated by gentle pipetting in 0.25% (wt/vol) trypsin solution supplemented with 0.05%(wt/vol) EDTA. The cells were isolated from the gonadal tissues by centrigugation at 300 × g [9] .
Primordial germ cell staining of the germinal crescent and gonad
The primordial germ cells obtained from the germinal crescent and gonadal regions were then identified by staining with Periodic Acid Schiff reaction (PAS reaction) [10] . The number of PGCs (PAS-positive cells) was counted under a light microscope.
Collection of blood and identification of primordial germ cells
After 55 h of incubation, 2 µL of blood was collected from individual embryos through the vitelline artery or the heart using a sharply cut glass tip of approximately 50 µm in diameter. When the blood was collected, the Primordial germ cells could easily be distinguished from the blood cells and counted because of their remarkably large size, large spherical nuclei, and the presence of refractive lipids in the cytoplasm under a phase contrast inverted microscope [11] .
Sexing of embryos
After PGC collection, a small piece of the tissue obtained from the embryo was digested in 50 µL of buffer composed of 10 mmol/L Tris, 1 mmol/L EDTA, 5% sodium dodecyl sulfate (SDS), and 10 µg/mL Proteinase K (pH 7.5) for 2 h at 38.5ºC. Then the sample was centrifuged at 15 000 × g for 5 min, and 5 µL of the supernatant was used for PCR reaction. PCR reactions were carried out using the W-linked (female-specific) Xho1 repeat sequence as described by Smith et al. [12] . Amplification of chicken β-actin was used as a control. The 
Statistical analysis
The data are presented as means ± SD. Statistical analyses were undertaken using SPSS version 11.5 software (SPSS Inc., Chicago, IL, USA). Paired independent-sample t-tests were used to test for significant differences between vehicle-treated and E2-treated embryos in PGC number at different stages of development. The percentage distribution of PGCs for significant difference was assessed using Fisher's exact test. Differences were regarded as significant at P < 0.05.
Results
Group1: E2 treatment at stage X prior to incubation
When assessed at stages 8-10 no effect on total number and distribution of PGCs could be detected (P > 0.05, Table 1 ).
The number of PGCs per microlitre of blood counted at stages 13-15 ranged from 0.04 ‰-0.19 ‰ in males and 0.06 ‰-0.23 ‰ in females and was not different between sexes and to the vehicle control (Table 1) .
Assessment at stages 28-30 revealed a significantly decreased number of PGCs in the male right anlage (125.6 ± 29.9) when compared with the vehicle control (516.2 ± 58.3) (P < 0.05, Table 1 ). However, the total number of PGCs was not different between sexes and when compared with the control.
Group 2: E2 treatment at stages 8-10 (after 30 h of incubation)
Evaluation of stages 28-30 yielded a significantly (P = 0.034) decreased mean number of PGCs in the male right anlage (166.5 ± 35.5) when compared to the control (429.2 ± 59.6). The total number of PGCs was not affected and not different between sexes.
The number of PGCs seen per microlitre of blood ranged from 0.07 ‰-0.19‰ in males and 0.05 ‰-0.16‰ in females it showed no effect of treatment and was not different between sexes and to the vehicle control (Table 1) .
Group 3: E2 treatment at stages 13-15 (after 55 h of incubation)
Following treatment with E2 the mean number of PGCs in the male right gonad was significantly lower (128.0 ± 47.3) compared with the control (482.6 ± 77.4) while the total number of PGCs was not affected and not different between sexes.
The asymmetry of primordial germ cells distribution in the gonads at stages 28-30
In all groups, it was found that the percentages in the male right gonads produced a significant decrease when compared with to that of their controls ( Table 2) . Each of the embryos displayed a left-sided asymmetry with respect to PGC distribution.
Discussion
To increase the likelihood of an effect of E2 treatment, E2 was injected directly into the embryonic compartment and not as was done with xeno-biotics, as in many other . 247 .
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Chicken PGCs have been reported to originate from the epiblast and to settle at the hypoblast of the pellucida area (germinal ridge). In doing so, the PGCs first enter the developing blood vessels at stages 10-12, circulate and migrate to the germinal ridge, where they develop into gonads. The PGCs then proliferate and differentiate to spermatogonia and oogonia. PGC proliferation and migration in birds has been reported as both passive and actively associated with chemo-attraction, extracellular matrix components and the vascular system [14] , the chemical signals involved remains to be identified. Estrogens obviously play a key role in gonadal differentiation in birds; therefore, genetically female chicken embryos can develop testes and a male phenotype if estrogen synthesis is inhibited by treatment with an aromatase inhibitor before sexual differentiation [1] . Estrogens are also considered an essential component for normal testicular development and function in other animals. For example, involvement of estrogens has recently been implicated by aromatase and estrogen receptor detection in human testicular germ cells and ejaculated spermatozoa [15] . ER 1 and ER 2 are clearly present in germ, Leydig and Sertoli cells in prepubertal and sexually mature boars [16] , and reducing endogenous estrogen production by inhibition of aromatase leads to increased proliferation of porcine Sertoli cells during the first 2 months of life.
Effects of E2 are usually considered to be genomic following interaction with nuclear estrogen receptors α and β [17] . However, 'non-genomic' effects of estrogens have also been characterized in several cell types, including those from the reproductive system and possibly spermatozoa [17] . These effects are mediated via either membrane-bound receptors or interaction with other proteins and/or membrane lipids. The presence of estrogen receptors in avian PGCs was not reported before day 6 of incubation, whereas estrogen receptor-mRNA was detected with expression being restricted to the left gonad of both female and male embryos [5] . During the early phase of gonadal development (between days 5.5 and 7 of incubation), estrogen binding sites are present in the germinal epithelium and medulla of the left gonad and in the medulla of the right gonad of both sexes [5] .
The present study indicated that treatment with E2 leads to a significant decrease in the number of the PGCs localized in the male right gonads. However, the underlying mechanisms of action are still to be determined. Both genomic and non-genomic mechanisms might be considered, even in a synergistic manner.
In Swartz's study [18] , testosterone was administrated to chick embryos at 33 h incubation in two forms: crystalline and dissolved in cottonseed oil. The PGC number decrease in gonadal area occurred in both groups at 5 days of incubation; however, in only the group receiving testosterone cypionate was the decrease found to be significant.
Meyer [10] found that the ratio of distribution of germ cells in the right and left gonads was uneven. The PGCs were initially localized evenly in both gonads, at least up to day 3, and the asymmetry began at stage 21 when approximately 65% of the PGCs colonized the left gonad [10] . This asymmetry might be utilized to determine the genetic sex of the embryo prior to histological sexual differentiation of gonads, occurring between 6 and 7 days [19] . In our study, each of the embryos displayed a left-sided asymmetry with respect to PGC distribution. E2 treated groups exhibited a significant decrease in the percentage of the PGCs in the male right gonads at stages 28-30. Normal asymmetry in the distribution of the PGCs favoring the left side in the male chick was affected in treatment of the groups (Table 2 ).
In conclusion, the present study has provided evidence that E2 has a significant and highly selective effect in decreasing the number of PGCs in the right gonad of male chicken embryos. The observation was made at stages 28-30. However, the underlying mechanisms of action including the time point of inhibition are unknown. These data are in agreement with earlier observations [1] , showing that estrogen affect chicken sexual development, such as gonadal differentiation and differentiation of accessory sex structures, and suggest that E2 is an important factor on PGC development and distribution in male chicken embryos.
